Shutting Down a ‘Dark Kinase’ May Defeat Treatment-Resistant Cancers
It happens to people with cancer every day; a first-line drug shrinks the tumor noticeably, but then the cancer returns, this time more aggressive and resistant to treatment than before. Now, Duke researchers are showing for the first time that blocking a key enzyme may help.
PGC Faculty Among Those Awarded Distinguished Professorships
Duke University has awarded distinguished professorships to 31 faculty members and will recognize them in a ceremony at the Washington Duke Inn on May 14.
Among those awarded are four Precision Genomics Collaboratory faculty members.
Gregory E. Crawford (Department of Pediatrics), Wilburt C. Davison Distinguished Professor
Brenna L Hughes (Department of Obstetrics and Gynecology), Edwin Crowell Hamblen Distinguished Professor of Reproductive Biology and Family Planning
CTSI Welcomes Clinical Research Equity Scholars in Partnership with Durham Tech
A unique collaboration launched four years ago between CTSI and Durham Technical Community College continues to thrive and recently welcomed the latest cohort of the Clinical Research Equity Scholars Program.
New Grant to Address Hidden Hypoxemia
Pulse oximetry, a commonly used method to monitor oxygen levels in patients, has long been trusted as a key diagnostic tool. However, for patients with darker skin tones, this technology may not be accurate. A new grant aims to help.
Olabisi among those elected to American Society for Clinical Investigation
Opeyemi Olabisi is among the 2025 researchers elected to the American Society for Clinical Investigation (ASCI), one of the nation’s oldest medical honor societies.
Activating Complex Regions of the Genome to Treat Rare Diseases
Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a rare genetic disease called Prader-Willi syndrome
Provider and Parks Partnership Shows Improvement in Pediatric Obesity Measures
Referrals by pediatric primary care providers to a community-led lifestyle program helped improve the health of pediatric patients with obesity, according to research led by Duke Health.
Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials
Tune Therapeutics announced the completion of its Series B fundraising round on Jan. 12, in which it raised $175 million to support clinical trials for its epigenome editor.
